tirzepatide obesity nejm New in the January 30, 2025, issue of NEJM: for Heart Failure and (SUMMIT trial) https://nej.md/4hRGaTY Continuation of Oral Anticoagulation during TAVI (POPular PAUSE TAVI trial) https://nej.md/3XllHys Lentiviral Gene Therapy In the SURMOUNT-1 trial (published
Description
29 DyrnaF.HanskeS.KruegerM.BechmannI
Patients would have to present a prescription issued after a doctor has assessed that the medicine is necessary
2,10 This may be due to an increase in free-radical burden associated with the metabolite valproate-4-ene
And I was like, This smells off. So, I dug into the research because Im a super nerd like that
